“The AI in Drug Discovery Summit was a thought-provoking meeting of the minds across disciplines!”

— AstraZeneca

“I really enjoyed attending the Summit. It was well-organized with interesting topics, panel discussions, and great opportunities to network. I look forward to attending again!”

— Benevolent AI

“The role of Artificial Intelligence in drug discovery and development is rapidly evolving. The AI Driven Drug Discovery Summit is a chance for participants to come up to speed across a range of areas, and interact with other stakeholders across the discipline.”

— Two Bear Capital

“The AI Driven Drug Discovery Summit offered excellent insights from both pharma and commercial AI efforts that are difficult to find outside of an event like this.”

— Qiagen

“This was a great opportunity to connect closely with practitioners in the AI drug discovery space. The quality of presentations, speakers, and panels was high, and it's really great to hear what different groups are doing at the forefront of our industry.”

— Nobias Therapeutics

“I found the conference to be comprehensive, delving into various facets of AI applications in drug discovery, ranging from target identification to the analysis of clinical trial data. The speakers provided valuable insights, and I gained a wealth of knowledge from their presentations. Additionally, the event afforded me the opportunity to network with experts in the field, further enhancing my understanding and connections within this dynamic industry.”

— Mariana Oncology

“This is a great place to meet people from pharma, biotech, and Venture Capital to see the use cases and trend of AI applications in drug discovery.”

— Xellar Biosystems

“The AI Driven Drug Discovery Summit was an incredible experience, filled with inspiring discussions and valuable connections. I’m excited to return this year and dive deeper into the latest trends and innovations in AI Drug discovery.”

— Fusion Fund

“I'm excited to speak at the 3rd Annual AI Driven Drug Discovery Summit in Boston! AI for biological discovery is still in its early days and we have so much to learn. I'm eager to share my perspective and engage with fellow innovators and thought leaders, as we collectively harness the transformative potential of AI to advance biological discovery and design.”

— Bayer